News & Updates
Showing Obstetrics & Gynaecology articles
Showing
Show Multimedia Only

KEYNOTE-522 final data boost pembrolizumab role in early breast cancer
09 Oct 2024
byAudrey Abella
Results from the phase III KEYNOTE-522 study presented at ESMO 2024 show a statistically significant and clinically meaningful improvement in overall survival (OS) with neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemo alone for previously untreated, high-risk, early-stage triple-negative breast cancer (TNBC).
09 Oct 2024

Epilepsy and ASM use in pregnancy increase morbidity and mortality risks in women and their offspring
03 Oct 2024
byElaine Tan
Women with epilepsy are at considerably higher risk of severe maternal and perinatal outcomes and increased risk of death during pregnancy and postpartum, and the use of antiseizure medications (ASM) further increases these risks, the largest study to date has found.
03 Oct 2024







